title: Growth hormone stimulates the proliferation of activated mouse T lymphocytes.
abstract: A modulatory role for GH on immune function has been suggested, but hormonal effects have been difficult to demonstrate with isolated cells. We have recently shown that GH receptors are present in murine hematopoietic tissues, with a lower receptor number in T lymphocytes than in B cells or macrophages. The binding of bovine GH (bGH) to murine splenocytes is increased after T cell activation with either concanavalin A or anti-CD3 antibody. In the present study, we show that bGH is able to stimulate the proliferation of activated murine T cells. Splenocytes were stimulated with either Con A or anti-CD3 antibody; addition of the mitogen resulted in increased [3H]thymidine uptake. When added together with the mitogen to the culture medium, bGH was able to further stimulate thymidine uptake. A bell-shaped dose-response curve was observed. bGH was able to increase cell proliferation by 2.5-fold over the effect of anti-CD3 alone. The amplitude of the bGH response was greater in unfractionated splenocytes than in purified T lymphocytes or thymocytes. Splenocytes were also stimulated by lipopolysaccharide, a B cell-specific mitogen; no change in the level of bGH binding was observed during activation of B cells, and no effect of bGH on the proliferative response of splenocytes to lipopolysaccharide was detected. The GH proliferative effect on T lymphocytes is probably direct and not through locally produced insulin-like growth factor I, because insulin-like growth factor I did not affect the cell proliferation when added at concentrations ranging from 10(-9)-10(-7) M. Ovine PRL was also able to stimulate [3H]thymidine uptake in splenocytes and thymocytes, and a synergistic effect was observed when bGH and ovine PRL were added together at 10(-8) M. Our findings support the biological significance of the GH receptors identified in murine T lymphocytes and confirm the role of GH in the regulation of immune functions.
authors.affiliation: INSERM U-344, Endocrinologie Moléculaire, Université Paris V, Hôpital Necker, France.
authors.forename: M C
authors.initials: MC
authors.lastname: Postel-Vinay
authors.forename: V
authors.initials: V
authors.lastname: de Mello Coelho
authors.forename: M C
authors.initials: MC
authors.lastname: Gagnerault
authors.forename: M
authors.initials: M
authors.lastname: Dardenne
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001402:B-Lymphocytes / Q000166:cytology; D017252:CD3 Complex / Q000276:immunology; D002417:Cattle; D002455:Cell Division / Q000187:drug effects*; D003208:Concanavalin A / Q000494:pharmacology; D005260:Female; D013006:Growth Hormone / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011388:Prolactin / Q000494:pharmacology; D011986:Receptors, Somatotropin / Q000032:analysis; D013154:Spleen / Q000166:cytology; D013601:T-Lymphocytes / Q000166:cytology*
chemical_list: D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D011986:Receptors, Somatotropin; D003208:Concanavalin A; D011388:Prolactin; D013006:Growth Hormone